Gentian Diagnostics ASA (OSL:GENT)
54.80
+1.80 (3.40%)
Oct 27, 2025, 3:52 PM CET
Gentian Diagnostics ASA Revenue
Gentian Diagnostics ASA had revenue of 41.84M NOK in the quarter ending September 30, 2025, with 27.94% growth. This brings the company's revenue in the last twelve months to 172.52M, up 17.42% year-over-year. In the year 2024, Gentian Diagnostics ASA had annual revenue of 152.07M with 12.52% growth.
Revenue (ttm)
172.52M
Revenue Growth
+17.42%
P/S Ratio
4.90
Revenue / Employee
2.74M
Employees
63
Market Cap
845.14M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 152.07M | 16.92M | 12.52% |
| Dec 31, 2023 | 135.15M | 23.23M | 20.76% |
| Dec 31, 2022 | 111.92M | 11.91M | 11.91% |
| Dec 31, 2021 | 100.01M | 21.13M | 26.78% |
| Dec 31, 2020 | 78.88M | 23.50M | 42.43% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Medistim ASA | 662.18M |
| Nordhealth AS | 578.17M |
| Navamedic ASA | 523.56M |
| Photocure ASA | 522.86M |
| Omda AS | 458.96M |
| Vistin Pharma ASA | 452.25M |
| ContextVision AB | 122.97M |
| ArcticZymes Technologies ASA | 104.33M |